Dr. Brinda Emu Provides Insight into HIV Monoclonal Antibody Ibalizumab

Brinda Emu, MD, of the Infectious Diseases department at Yale University, offers insight into monoclonal antibody ibalizumab. Dr. Emu explains that the antiretroviral binds CD4—the primary receptor for HIV—and inhibits the viral entry process. Ibalizumab is active against all major HIV clades.